تخطي إلى المحتوى الرئيسي

توكسين البوتولينوم النوع A للصداع النصفي

البوتوكس

Botulinum toxin type A is a specialist treatment for migraine.

To be eligible for this treatment you must have headaches for 15 or more days each month, with migraine headaches being on at least eight of these days.

It will be given by multiple injections into the muscles around your head and neck.

If you experience any difficulty swallowing, speaking, or breathing after the treatment, speak with your doctor immediately.

نظرة سريعة

  • Botulinum toxin type A is a neurotoxin used to prevent chronic migraine headaches.

  • It is given by injection into muscles around the head and neck.

  • To be eligible, you must have frequent headaches and have tried other migraine prevention medicines.

  • Injections are typically repeated every 12 weeks if the treatment is successful.

  • Common side-effects include pain at injection sites and muscle pain or weakness.

  • Seek immediate medical help if you experience difficulty swallowing, speaking, or breathing.

About botulinum toxin type A

نوع الدواء

A bacterial neurotoxin

يستخدم لـ

To prevent headaches associated with chronic migraine in adults

يُعرف أيضًا باسم

Onabotulinumtoxin A (in US); Alluzience®; Azzalure®; Bocouture®; Botox®; Nuceiva®; Xeomin®

متوفر كـ

حقن

Botulinum toxin type A is a protein substance which is produced by the bacterium Clostridium botulinum. It is a neurotoxin which means that it interferes with the way nerves work. To be eligible for this treatment you must have headaches for 15 or more days each month, with migraine headaches being on at least eight of these days. You must also have tried several other medicines to prevent migraine before this treatment is prescribed for you.

Botulinum toxin type A is thought to work in chronic migraine by relaxing muscles and by blocking the pain signals which are involved in the development of a migraine. These actions may have the effect of stopping a migraine headache from being triggered.

Botulinum toxin injections are also used for other reasons (including cosmetic purposes, muscle spasms, bladder problems, and excessive sweating). This leaflet does not cover the use of botulinum toxin type A in these ways.

Before being treated with botulinum toxin type A

Some medicines are not suitable for people with certain conditions, and sometimes a medicine may only be used if extra care is taken. For these reasons, before being treated with botulinum toxin type A for migraine, make sure that your doctor knows:

  • إذا كنتِ حاملاً، تحاولين الإنجاب أو تقومين بالرضاعة الطبيعية.

  • If you have an infection or any swelling near any of the areas that will be injected.

  • If you have any muscle problems, particularly any muscle weakness.

  • If you have ever had any difficulty in swallowing or with your breathing.

  • إذا كنت تتناول أي أدوية أخرى. يشمل ذلك أي أدوية تتناولها والتي يمكن شراؤها بدون وصفة طبية، بالإضافة إلى الأدوية العشبية والمكملات الغذائية.

  • إذا كنت قد تعرضت في أي وقت مضى لرد فعل تحسسي تجاه دواء.

How you will be given botulinum toxin type A

  • Before you start the treatment, ask to read the manufacturer's printed information leaflet from inside the pack. It will give you more information about Botox® and will provide you with a full list of the side-effects which you may experience from having it.

  • You will be given botulinum toxin type A by a doctor who is trained in the use of this treatment. It will be injected into the muscles around your head and neck in several different places.

  • If the treatment proves successful for you, your doctor is likely to recommend that it is repeated every 12 weeks.

تحقيق أقصى استفادة من علاجك

  • If you are having an operation or dental treatment, tell the person carrying out the treatment that you have received botulinum toxin type A.

Can botulinum toxin type A cause problems?

Along with their useful effects, most medicines can cause unwanted side-effects although not everyone experiences them. The table below contains some of the most common ones associated with botulinum toxin type A. You will find a full list in the manufacturer's information leaflet supplied with your medicine. The unwanted effects may occur following a treatment session even if you have been free from side-effects on previous treatments. You should speak with your doctor or pharmacist if any of the following continue or become troublesome.

Common Botox® side-effects (these affect fewer than 1 in 10 people)

ماذا يمكنني أن أفعل إذا واجهت هذا؟

Pain at the sites where you have been injected, neck and muscle pain or stiffness, muscle weakness, skin rash and itching

These should soon pass, but if any becomes troublesome, speak with your doctor

Worsening of headache or migraine

تحدث مع طبيبك حول هذا

Eyelid drooping or swelling, paralysis of the face

تحدث مع طبيبك حول هذا

مهم: if you experience any difficulty swallowing, speaking, or breathing, speak with your doctor immediately or go to your local accident and emergency department straightaway.

If you experience any other symptoms which you think may be due to the treatment, speak with your doctor or pharmacist for further advice.

معلومات هامة عن جميع الأدوية

معلومات هامة عن جميع الأدوية

هذا الدواء لك. لا تعطه لأشخاص آخرين حتى لو بدت حالتهم مشابهة لحالتك.

If you buy any medicines, check with a pharmacist that they are safe to use alongside this treatment.

لا تحتفظ بالأدوية منتهية الصلاحية أو غير المرغوب فيها. خذها إلى صيدليتك المحلية التي ستتولى التخلص منها نيابة عنك.

إذا كان لديك أي أسئلة حول هذا الدواء، اسأل الصيدلي الخاص بك.

الإبلاغ عن الآثار الجانبية لدواء أو لقاح

إذا واجهت آثارًا جانبية، يمكنك الإبلاغ عنها عبر الإنترنت من خلال موقع بطاقة صفراء.

مدقق الأعراض

غير متأكد من خلط الأدوية؟

تحقق من التفاعلات المحتملة بين الأدوية والمكملات الغذائية والأطعمة قبل تناولها معًا.

الأسئلة الشائعة

What is botulinum toxin type A and how does it relate to Botox®?

Botulinum toxin type A is a protein substance derived from a bacterium which primarily interferes with nerve function. Botox® is one of several brand names, alongside others like Alluzience®, Azzalure®, Bocouture®, and Xeomin®, under which botulinum toxin type A is available for medical treatments, including chronic migraine.

Are there specific criteria I need to meet to be eligible for botulinum toxin type A treatment for migraine?

Yes, to be eligible for this treatment for migraine, you must experience headaches for 15 or more days each month, with migraine headaches occurring on at least eight of those days. Additionally, you need to have attempted and found insufficient several other migraine prevention medicines before this treatment will be considered.

How often will I need to receive botulinum toxin type A injections if they are effective for my migraines?

If the treatment is successful in managing your chronic migraines, your doctor will likely recommend that the injections are repeated approximately every 12 weeks.

Are there any specific situations where I should inform other healthcare professionals about my botulinum toxin type A treatment?

Yes, if you are planning to have an operation or dental treatment, it is important to inform the person carrying out the procedure that you have received botulinum toxin type A injections.

What should I do if I experience rare but serious side effects like difficulty swallowing or breathing after treatment?

If you experience any serious side effects such as difficulty swallowing, speaking, or breathing, you should seek immediate medical attention. Contact your doctor straightaway or go directly to your local accident and emergency department.

قراءة إضافية ومراجع

عن المؤلفعرض السيرة الذاتية الكاملة

صورة المؤلف

مايكل ستيوارت، MRPharmS

مدير مراجعة النشرات الطبية – متعاقد، صيدلي

بكالوريوس الصيدلة (مع مرتبة الشرف)، عضو الجمعية الملكية للصيادلة

مايكل هو صيدلي مجتمعي يمارس عمله في منطقة ميدلاندز وجنوب يوركشاير ولديه أكثر من 20 عامًا من الخبرة في تقديم المشورة بشأن الأدوية والحالات الطبية. لديه خلفية قوية في تدريب الرعاية الصحية، حيث قام بإنتاج وتقديم دورات تدريبية لفرق الصيدلة وموظفي دور الرعاية السكنية، بما في ذلك الممرضات. كما ساهم في مجالس استشارية للصيدلة لإدارة الحالات ذات الحدة المنخفضة في المجتمع.

حول المراجع

صورة المؤلف

سيد داجاني

تخرج سلطان دجاني من كلية الصيدلة في لندن عام 1994 وأصبح أصغر عضو منتخب في مجلس الجمعية الملكية للصيدلة منذ تأسيسها في عام 1842.

تاريخ المقال

تمت كتابة المعلومات على هذه الصفحة ومراجعتها من قبل أطباء مؤهلين.

  • المراجعة التالية مستحقة: 18 سبتمبر 2026
  • 19 سبتمبر 2023 | أحدث إصدار

    آخر تحديث بواسطة

    مايكل ستيوارت، MRPharmS

    مراجعة من قبل

    سيد داجاني
أداة التحقق من أهلية لقاح الإنفلونزا

اسأل، شارك، تواصل.

تصفح المناقشات، اطرح الأسئلة، وشارك التجارب عبر مئات المواضيع الصحية.

اشترك في النشرة الإخبارية للمرضى

جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.

يرجى إدخال عنوان بريد إلكتروني صالح

من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.